Diseases, Conditions, Syndromes

Ivacaftor may reduce common infections in patients with CF

Patients with cystic fibrosis who take ivacaftor appear to have fewer respiratory infections over time than those not taking the drug, according to new research published online in the Annals of the American Thoracic Society.

Diseases, Conditions, Syndromes

Shaky scaffold changes lung infrastructure

Our lungs work tirelessly all through the day to keep us breathing, seamlessly expanding and contracting. When lung tissue becomes damaged and scarred, it can lose its flexibility, making it harder to breathe.

Medical research

A new target for the treatment of idiopathic pulmonary fibrosis

An article published in Experimental Biology and Medicine identifies a new target for the treatment of idiopathic pulmonary fibrosis. The study, led by Dr. Huaping Dai in the Department of Pulmonary and Critical Care Medicine ...

Diseases, Conditions, Syndromes

Adding clinical variables improves accuracy of lung allocation score

Implemented back in 2005, the lung allocation score is used to prioritize patients awaiting lung transplants in the United States. Sicker transplant candidates have a higher calculated score and are placed at the top of the ...

Diseases, Conditions, Syndromes

Common virus linked to faster disease progression in cystic fibrosis

A new study has found that cystic fibrosis patients who have a common virus may experience faster disease progression than patients who do not have the virus. Signs of faster cystic fibrosis disease progression included earlier ...

Diseases, Conditions, Syndromes

Protein linked to cancer growth drives deadly lung disease

A protein associated with cancer growth appears to drive the deadly lung disease known as idiopathic pulmonary fibrosis, according to new research from Cedars-Sinai. The discovery, made in laboratory mice and human tissue ...

page 1 from 23